Systemic sclerosis-associated interstitial lung disease: Role of the oesophagus in outcomes

被引：3
|
作者：
Strek, Mary E. [1 ]
机构：
[1] Univ Chicago, Med Ctr, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA
来源：
RESPIROLOGY | 2018年 / 23卷 / 10期
关键词：
oesophageal disease; hiatal hernia; interstitial lung disease; systemic sclerosis; IDIOPATHIC PULMONARY-FIBROSIS; GASTROESOPHAGEAL-REFLUX; MANAGEMENT;
D O I：
10.1111/resp.13335
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：885 / 886
页数：2
相关论文
共 50 条
  • [31] Interstitial Lung Disease Associated with Systemic Sclerosis
    Mismetti, Valentine
    Si-Mohamed, Salim
    Cottin, Vincent
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (03) : 342 - 364
  • [32] Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
    Rahaghi, Franck F.
    Hsu, Vivien M.
    Kaner, Robert J.
    Mayes, Maureen D.
    Rosas, Ivan O.
    Saggar, Rajan
    Steen, Virginia D.
    Strek, Mary E.
    Bernstein, Elana J.
    Bhatt, Nitin
    Castelino, Flavia V.
    Chung, Lorinda
    Domsic, Robyn T.
    Flaherty, Kevin R.
    Gupta, Nishant
    Kahaleh, Bashar
    Martinez, Fernando J.
    Morrow, Lee E.
    Moua, Teng
    Patel, Nina
    Shlobin, Oksana A.
    Southern, Brian D.
    Volkmann, Elizabeth R.
    Khanna, Dinesh
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [33] Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
    Meier, C.
    Freiburghaus, K.
    Bovet, C.
    Schniering, J.
    Allanore, Y.
    Distler, O.
    Nakas, C.
    Maurer, B.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [34] The hidden costs of living with systemic sclerosis-associated interstitial lung disease
    Parfrey, Helen
    RESPIROLOGY, 2022, 27 (07) : 486 - 487
  • [35] Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
    Bonhomme, Olivier
    Andre, Beatrice
    Gester, Fanny
    de Seny, Dominique
    Moermans, Catherine
    Struman, Ingrid
    Louis, Renaud
    Malaise, Michel
    Guiot, Julien
    RHEUMATOLOGY, 2019, 58 (09) : 1534 - 1546
  • [36] FAM13A polymorphism is associated with a usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease
    Bernstein, Elana J.
    Boin, Francesco
    Elicker, Brett
    Luo, Yiming
    Ren, Yawen
    Zhang, Meng
    Varga, John
    Assassi, Shervin
    RHEUMATOLOGY, 2024,
  • [37] Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study
    Li, Qiang
    Wallace, Laura
    Patnaik, Padmaja
    Alves, Margarida
    Gahlemann, Martina
    Kohlbrenner, Veronika
    Raabe, Christina
    Wang, Jocelyn R.
    Garry, Elizabeth M.
    RHEUMATOLOGY, 2021, 60 (04) : 1915 - 1925
  • [38] Understanding diagnostic pathways in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: A retrospective cohort study
    Assassi, Shervin
    Shao, Nan
    Yin, Ziwei
    Volkmann, Elizabeth R.
    Zoz, Donald F.
    Leonard, Thomas B.
    MEDICINE, 2022, 101 (32) : E29993
  • [39] Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Daoussis, Dimitrios
    Andonopoulos, Andrew P.
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (06) : 841 - 842
  • [40] Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Dimitrios Daoussis
    Andrew P. Andonopoulos
    Rheumatology International, 2011, 31 : 841 - 842
12345